Buenos Aires 2023 - Día 1 - Panel Introducción a los Esfuerzos Regionales en el Ámbito de la Reducción de la Demanda de Drogas
Presented as part of the Conferencia Regional de ISSUP Buenos Aires event, on the 19th of April, 2023
Search
Buenos Aires 2023 - Día 1 - Ceremonia de Apertura
Presented as part of the Conferencia Regional de ISSUP Buenos Aires event, on the 19th of April, 2023
Training of Master Trainers on the "NAVCHETNA" module
ISSUP India chapter in collaboration with the Ministry of Education (MoE), the Ministry of Social Justice & Empowerment (MSJE), Government of India developed a teacher trainer resource module called "NAVCHETNA: A new Consciousness on Life...
Introduction to SAMHSA 4E’s Modern and Comprehensive Prevention System
SAMHSA recently introduced the 4 E’s as a “Modern and Comprehensive Prevention System” to support the work of prevention providers in States and communities.
The 4 E’s: Early Action, Easy Access, Equitable Opportunities and Effective...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
How alcohol consumption contributes to chronic pain
A team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and hypersensitivity.
Chronic alcohol consumption may make people more sensitive to pain through two different molecular mechanisms -- one driven by...
National Drug Observatories from Latin American and Caribbean countries meet in Lisbon for ‘COPOLAD week’
National Drug Observatories (NDOs) from Latin American and Caribbean (LAC) countries are gathering in Lisbon from 22–26 May for a week of activities under the COPOLAD III programme.
The overarching theme of the initiative will be...
Teens and substance use — what can parents do?
Objective: To help adults manage risks relating to adolescent substance use in line with evidence-based prevention principles.
Background: Smoking and drinking among 15–16-year-old school students are showing signs of decline, but there...
PMGR: Recovery Kentucky: A Successful Model of Addressing Substance Use Disorder
The May 2023 Preventive Medicine Grand Rounds (PMGR) features Recovery Kentucky, a social model program that provides housing and recovery services for rural Kentuckians dealing with substance use disorder. The program is led by the...
Understanding the risks of mixing drugs
February 17, 2022
Mixing drugs, also known as polysubstance use, occurs when two or more drugs are taken together or within a short time period, intentionally or unintentionally. Even if someone has mixed drugs before, or mixes drugs often...
Datos sobre el uso de múltiples sustancias
Fuente: https://www.cdc.gov/stopoverdose/polysubstance-use/pdf/Spanish-Polysubstance-Factsheet-508.pdf
¿Qué es el uso de múltiples sustancias?
El uso de más de una droga, lo que se conoce como uso de múltiples sustancias, es frecuente...
Polysubstance Use Facts
What is polysubstance use?
The use of more than one drug, also known as polysubstance use, is common. This includes when two or more are taken together or within a short time period, either intentionally or unintentionally.
Intentional...
Estándar Mexicano de Competencias de la Consejería en Adicciones
El objetivo del Estándar es establecer las competencias básicas e indispensables en el ejercicio de la consejería en adicciones en nuestro país, principalmente las que se ejercen en establecimientos con modalidad residencial y que sirven de...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides
Para publicación inmediata: 24 de mayo del 2023
Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi...
Rome Consensus 2.0 Summit conclusions
Following the conclusion of the Rome Consensus 2.0 Summit, we are still enthusiastic to have met so many partners in person and for the good outcome of the event, which was possible thanks to the availability and contribution of every single person.
Covering Substance Use and Addiction Responsibly
Stories about substance use and addiction can be among the thorniest that health and science reporters encounter. This topic carries a long history of marginalizing the people most directly affected. In addition, deeply ingrained societal misconceptions about substance use make it difficult to separate fact from fiction
Microglia transcriptional profiling in major depressive disorder shows inhibition of cortical grey matter microglia
Abstract
Background
Microglia have been implicated in the pathophysiology of major depressive disorder (MDD), but information on biological mechanisms is limited. Therefore, we investigated the gene expression profile of microglial cells...
Nursing training and its association with burnout syndrome among Mexican undergraduate students
Abstract:
Introduction. Previous data suggest that healthcare students, such as nursing students, might have a differential risk of presenting burnout syndrome caused by the stress they are subjected to. However, the evidence is still...
Mental illness attitudes in medical education: Assessing the stigma in medical students
Abstract:
Introduction. Factors affecting the quality of physician care include a shortage of trained staff, stigma, and discrimination.
Objective. The objective was to compare the intensity of stigmatization before and after a Psychiatry...